# Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance), Division 2: Certificates in effect in Northern Ireland


Where a certificate granted solely on the basis of a NI authorisation was in effect before 1 January 2025, and a GB authorisation for the same product—
(a)was granted on or after the date on which the certificate took effect but before 1 January 2025,
(b)is in effect on or before 31 December 2024 but a valid notification has not been made to the comptroller in accordance with Article 13A, and
(c)becomes a transitioned-UK authorisation,
the certificate shall continue, on and after 1 January 2025, to have effect solely in the territory of Northern Ireland on the basis of the transitioned-UK authorisation for that product.

---
Source: https://www.legislation.gov.uk/eur/2009/469/annex/III/division/2. (the official version)
Page: https://openlegislation.uk/eu-regulation-2009-469/annex-III/division-2.
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.